Does ERBITUX SOLN FOR INF /ML Cause Decreased appetite? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Decreased appetite have been filed in association with ERBITUX SOLN FOR INF /ML. This represents 10.9% of all adverse event reports for ERBITUX SOLN FOR INF /ML.
6
Reports of Decreased appetite with ERBITUX SOLN FOR INF /ML
10.9%
of all ERBITUX SOLN FOR INF /ML reports
2
Deaths
1
Hospitalizations
How Dangerous Is Decreased appetite From ERBITUX SOLN FOR INF /ML?
Of the 6 reports, 2 (33.3%) resulted in death, 1 (16.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERBITUX SOLN FOR INF /ML. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ERBITUX SOLN FOR INF /ML Cause?
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)